Zhang, Bingyu
Li, Lu
Lu, Yiwen
Guo, Jingchuan
Bian, Jiang
Salmon, John B.
Stetson, Robert L.
Horst, Michael A.
Sridhara, Srinivas K.
Schnall, Mitchell D.
Mahoney, Kevin B.
Asch, David A.
Chen, Yong https://orcid.org/0000-0003-0835-0788
Article History
Received: 13 April 2025
Accepted: 20 October 2025
First Online: 11 February 2026
Declarations
:
: This study was reviewed and classified as exempt by the University of Pennsylvania Institutional Review Board.
: This manuscript has been posted on medRxiv: .
: Dr. David A. Asch is a partner and part owner of VAL Health and serves on the advisory boards of Thrive Global and Morpheus. Dr. Yong Chen reported receiving personal fees from Merck & Co., Inc. outside the submitted work. All other co-authors have no conflicts of interest to report.